Position dérivée des transactions déclarées les plus récentes. Non ajustée des splits ni des conversions de classes d'actions.
| Émetteur | Actions | Source | Dernière tx | Détail |
|---|---|---|---|---|
| Oruka Therapeutics, Inc. | 6 000 | déclaré | 30 janv. 2024 | tx 18+164 414 |
| Nivalis Therapeutics, Inc. | 0 | déclaré | 20 mai 2024 | tx 30+209 525−125 955 |
| Date | Type | Émetteur | Quantité | Prix | Signaux |
|---|---|---|---|---|---|
| 20 mai 2024 | OTHER | Nivalis Therapeutics, Inc. | 50 000 | — | |
| 20 mai 2024 | OTHER | Nivalis Therapeutics, Inc. | 2 868 | — | deriv |
| 20 mai 2024 | OTHER | Nivalis Therapeutics, Inc. | 3 075 | — | deriv |
| 20 mai 2024 | OTHER | Nivalis Therapeutics, Inc. | 1 912 | — | deriv |
| 20 mai 2024 | OTHER | Nivalis Therapeutics, Inc. | 7 650 | — | deriv |
| 20 mai 2024 | OTHER | Nivalis Therapeutics, Inc. | 17 500 | — | deriv |
| 20 mai 2024 | OTHER | Nivalis Therapeutics, Inc. | 7 650 | — | deriv |
| 20 mai 2024 | OTHER | Nivalis Therapeutics, Inc. | 7 650 | — | deriv |
| 20 mai 2024 | OTHER | Nivalis Therapeutics, Inc. | 10 000 | — | deriv |
| 20 mai 2024 | OTHER | Nivalis Therapeutics, Inc. | 10 000 | — | deriv |
| 20 mai 2024 | OTHER | Nivalis Therapeutics, Inc. | 7 650 | — | deriv |
| 30 janv. 2024 | GRANT_AWARD | Oruka Therapeutics, Inc. | 6 000 | 0.00 USD | deriv |
| 02 janv. 2024 | GRANT_AWARD | Nivalis Therapeutics, Inc. | 17 500 | 0.00 USD | deriv |
| 03 janv. 2023 | GRANT_AWARD | Nivalis Therapeutics, Inc. | 10 000 | 0.00 USD | deriv |
| 15 déc. 2022 | GRANT_AWARD | Oruka Therapeutics, Inc. | 6 000 | 0.00 USD | deriv |
| 03 janv. 2022 | GRANT_AWARD | Nivalis Therapeutics, Inc. | 10 000 | 0.00 USD | deriv |
| 23 sept. 2021 | SALE | Nivalis Therapeutics, Inc. | 15 000 | 10.08 USD | |
| 21 sept. 2021 | PURCHASE | Nivalis Therapeutics, Inc. | 10 000 | 9.80 USD | |
| 12 mai 2021 | PURCHASE | Oruka Therapeutics, Inc. | 10 000 | 3.19 USD | |
| 05 mai 2021 | PURCHASE | Oruka Therapeutics, Inc. | 10 000 | 3.23 USD | |
| 12 janv. 2021 | GRANT_AWARD | Oruka Therapeutics, Inc. | 12 000 | 0.00 USD | deriv |
| 04 janv. 2021 | GRANT_AWARD | Nivalis Therapeutics, Inc. | 7 650 | 0.00 USD | deriv |
| 18 déc. 2020 | PURCHASE | Oruka Therapeutics, Inc. | 10 000 | 4.16 USD | |
| 19 nov. 2020 | PURCHASE | Nivalis Therapeutics, Inc. | 10 000 | 8.03 USD | |
| 25 sept. 2020 | PURCHASE | Oruka Therapeutics, Inc. | 5 000 | 4.28 USD |
2 achats déclarés après au moins 12 mois de silence — dernière occurrence le 21 sept. 2020.